Bright Minds Biosciences, Inc. (DRUG)
78.87
-1.70
(-2.11%)
USD |
NASDAQ |
Feb 13, 12:20
Bright Minds Biosciences Total Liabilities (Quarterly) : 1.708M for Sept. 30, 2025
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Eli Lilly & Co. | -- |
| ACADIA Pharmaceuticals, Inc. | 413.50M |
| Alnylam Pharmaceuticals, Inc. | 4.618B |
| Savara, Inc. | 46.54M |
| BioMarin Pharmaceutical, Inc. | 1.558B |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 60.67M |
| Shareholders Equity (Quarterly) | 58.97M |
| Debt to Equity Ratio | 0.0015 |
| Current Ratio | 36.10 |
| Net Debt Paydown Yield | -0.00% |